Comment on 'Why is the rectal route for NSAIDs favorable for preventing post-ERCP pancreatitis?'. Lin H, Bao L. Pancreatology 2025 Sep 1:S1424-3903(25)00592-7. doi: 10.1016/j.pan.2025.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lin H, Bao L. Comment on 'Why is the rectal route for NSAIDs favorable for preventing post-ERCP pancreatitis?'. Pancreatology 2025 Sep 1:S1424-3903(25)00592-7. doi: 10.1016/j.pan.2025.
PMID: 41046219